Results 141 to 150 of about 1,005 (173)

Interim analysis of a post-authorization safety study of pitolisant in treating narcolepsy: A real-world European study

open access: yesSleep Medicine
Background: Narcolepsy is a chronic sleep disorder characterized mainly by excessive daytime sleepiness (EDS) and cataplexy in the case of narcolepsy type 1 (NT1).
Svenja Happe, Isabelle Lecomte
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Quantification of Pitolisant: A RP - HPLC study

YMER Digital, 2022
Objective An attempt was made to develop a simple, isocratic and robust reverse phase high performance liquid chromatographic method for Pitolisant. Material and methods An Inertsil octa decyl silane column and photo diode array detector were employed for the quantification of Pitolisant at 268 nm using a mobile phase consisting of acetonitrile and 0.1
Sowjanya Gummadi   +1 more
openaire   +1 more source

Pitolisant

Reactions Weekly, 2022
openaire   +1 more source

Pitolisant

Reactions Weekly
Gonzalo Labarca, Bhajan Singh
  +4 more sources

Antihistamine agents and pitolisant might be useful for anorexia nervosa

Medical Hypotheses, 2019
This hypothesis is that patients with anorexia nervosa (AN) demonstrate derangement in the histamine central nervous system. It might be possible to ameliorate these by careful use of histamine receptor antagonists targeting Histamine 1, 2, or 3 receptors. Histamine 3 receptors are exclusively present in the brain.
openaire   +2 more sources

Modafinil/pitolisant

Reactions Weekly, 2023
openaire   +1 more source

Pitolisant hydrochloride

Drugs of the Future, 2013
null Pierre, S., null Scholich, K.
openaire   +1 more source

Pitolisant

Reactions Weekly, 2012
openaire   +1 more source

Home - About - Disclaimer - Privacy